Meta-analysis of vascular endothelial growth factor variations in amyotrophic lateral sclerosis: increased susceptibility in male carriers of the −2578AA genotype

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Medical Genetics

• Publication date

  2008-04-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1136/jmg.2008.058222PMID 18413368
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Amyotrophic Lateral Sclerosis (ALS)

  2009cited by this paper
• Absence of angiogenic genes modification in Italian ALS patients.

  2008cited by this paper
• Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database

  2007influential reference
• ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study.

  2007cited by this paper
• Heritability for Plasma VEGF Concentration in the Stanislas Family Study

  2007influential reference
• High erythropoietin and low vascular endothelial growth factor levels in cerebrospinal fluid from hypoxemic ALS patients suggest an abnormal response to hypoxia.

  2007cited by this paper
• Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data.

  2007cited by this paper
• Vascular Endothelial Growth Factor Overexpression Delays Neurodegeneration and Prolongs Survival in Amyotrophic Lateral Sclerosis Mice

  2007cited by this paper
• Whole-genome analysis of sporadic amyotrophic lateral sclerosis.

  2007cited by this paper
• Heterogeneity in motoneuron disease.

  2007cited by this paper
• ALS: a disease of motor neurons and their nonneuronal neighbors.

  2006cited by this paper
• Molecular biology of amyotrophic lateral sclerosis: insights from genetics

  2006cited by this paper
• Genetics of familial and sporadic amyotrophic lateral sclerosis.

  2006cited by this paper
• The molecular genetics of non-ALS motor neuron diseases.

  2006cited by this paper
• Another angiogenic gene linked to amyotrophic lateral sclerosis.

  2006cited by this paper
• Review ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors

  2006cited by this paper
• Expression of Vascular Endothelial Growth Factor and Its Receptors in the Central Nervous System in Amyotrophic Lateral Sclerosis

  2006cited by this paper
• Possible gender-dependent association of vascular endothelial growth factor (VEGF) gene and ALS

  2006cited by this paper
• VEGF C2578A polymorphism does not contribute to amyotrophic lateral sclerosis susceptibility in sporadic Chinese patients

  2006cited by this paper
• VEGF at the neurovascular interface: therapeutic implications for motor neuron disease.

  2006cited by this paper
• Paradoxical response of VEGF expression to hypoxia in CSF of patients with ALS

  2006cited by this paper
• Lack of association of VEGF promoter polymorphisms with sporadic ALS

  2006cited by this paper
• Screening of the regulatory and coding regions of vascular endothelial growth factor in amyotrophic lateral sclerosis

  2005cited by this paper
• Lack of association between VEGF polymorphisms and ALS in a Dutch population

  2005cited by this paper
• Common mechanisms of nerve and blood vessel wiring

  2005cited by this paper
• Integrating case-control and TDT studies.

  2005cited by this paper
• Angiogenesis in life, disease and medicine

  2005cited by this paper
• Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS

  2005cited by this paper
• From angiogenesis to neuropathology

  2005cited by this paper
• VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model

  2004cited by this paper
• VEGF PROMOTER HAPLOTYPE AND AMYOTROPHIC LATERAL SCLEROSIS (ALS)

  2004cited by this paper
• VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death

  2003cited by this paper
• Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease

  2003cited by this paper
• Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration

  2001cited by this paper
• Replication validity of genetic association studies

  2001cited by this paper
• Trim and Fill: A Simple Funnel‐Plot–Based Method of Testing and Adjusting for Publication Bias in Meta‐Analysis

  2000cited by this paper
• Changes in Serum Levels of Vascular Endothelial Growth Factor in Males and Females Throughout Life

  2000influential reference

• Brain–body mechanisms contribute to sexual dimorphism in amyotrophic lateral sclerosis

  2024cites this paper
• Lack of association of VEGF-A polymorphisms and susceptibility to amyotrophic lateral sclerosis and multiple sclerosis: A systematic review and meta-analysis

  2023cites this paper
• Advances in sequencing technologies for amyotrophic lateral sclerosis research

  2023cites this paper
• Changes in adenosine receptors and neurotrophic factors in the SOD1G93A mouse model of amyotrophic lateral sclerosis: Modulation by chronic caffeine

  2022cites this paper
• Biomarkers and molecular mechanisms of Amyotrophic Lateral Sclerosis

  2022cites this paper
• A strong association between VEGF-A rs28357093 and amyotrophic lateral sclerosis: a brazilian genetic study

  2022cites this paper
• Changes in adenosine and neurotrophic signaling in the SOD1G93A mouse model of amyotrophic lateral sclerosis: modulation by chronic caffeine intake

  2022cites this paper
• VEGF and Neuronal Survival

  2022cites this paper
• Confirmation of early non-bulbar onset of amyotrophic lateral sclerosis in Spanish league soccer players.

  2021cites this paper
• Neurotrophic Therapy for ALS/MND

  2021cites this paper
• NRF2 as a therapeutic opportunity to impact in the molecular roadmap of ALS.

  2021cites this paper
• Identifying putative cerebrospinal fluid biomarkers of amyotrophic lateral sclerosis in a north Indian population

  2020cites this paper
• Modern approaches in gene therapy of motor neuron diseases

  2020cites this paper
• The role of glia in protein aggregation.

  2020cites this paper
• Intracerebroventricular delivery of vascular endothelial growth factor in patients with amyotrophic lateral sclerosis, a phase I study

  2020cites this paper
• Extensive transcriptomic study emphasizes importance of vesicular transport in C9orf72 expansion carriers

  2019influential citation
• Expression of the axon‐guidance protein receptor Neuropilin 1 is increased in the spinal cord and decreased in muscle of a mouse model of amyotrophic lateral sclerosis

  2019cites this paper
• The VEGF gene polymorphism in glioblastoma may be a new prognostic marker of overall survival.

  2019cites this paper
• The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease.

  2017cites this paper
• Effekte pharmakologischer Interventionen auf Muskelatrophie im Mausmodell der amyotrophen Lateralsklerose (ALS)

  2017cites this paper
• Identification of risk factors associated with onset and progression of amyotrophic lateral sclerosis using systematic review and meta‐analysis

  2017influential citation
• Genetics of amyotrophic lateral sclerosis.

  2017cites this paper
• Genetic studies of Russian patients with amyotrophic lateral sclerosis

  2016cites this paper
• Association between vascular growth factor gene-2578 C > A , + 1612 G > A polymorphism and the risk of renal cell carcinoma : a meta-analysis

  2016cites this paper
• Human Genetic Variation, Sport and Exercise Medicine, and Achilles Tendinopathy: Role for Angiogenesis-Associated Genes

  2016cites this paper
• VEGF mimic peptides: Potential applications in central nervous system therapeutics

  2016cites this paper
• Vascular endothelial growth factor: a neurovascular target in neurological diseases

  2016cites this paper
• Familial Amyotrophic Lateral Sclerosis.

  2015cites this paper
• The Role of Caffeine in Neurodegenerative Diseases: Possible Genetic and Cellular Signaling Mechanisms

  2015cites this paper
• Genetic causes of amyotrophic lateral sclerosis: new genetic analysis methodologies entailing new opportunities and challenges.

  2015cites this paper
• Investigation on association between five common polymorphisms in vascular endothelial growth factor and prototypes of autoimmune diseases.

  2015cites this paper
• Gender-specific association of polymorphisms in the 5′-UTR and 3′-UTR of VEGF gene with hypertensive patients

  2015influential citation
• Genetic heterogeneity of amyotrophic lateral sclerosis: Implications for clinical practice and research

  2014cites this paper
• Identification of Risk Factors Associated with Aetiology of Amyotrophic Lateral Sclerosis Based on Systematic Review and Meta-Analysis

  2014cites this paper
• The genetics and spread of Amyotrophic Lateral Sclerosis

  2014cites this paper
• Vascular endothelial growth factor and amyotrophic lateral sclerosis: The interplay with exercise and noninvasive ventilation

  2014influential citation
• Intermediate CAG Repeat Expansion in the ATXN2 Gene Is a Unique Genetic Risk Factor for ALS−A Systematic Review and Meta-Analysis of Observational Studies

  2014cites this paper
• Gene and protein therapies utilizing VEGF for ALS.

  2014cites this paper
• Selective vulnerability of motoneuron and perturbed mitochondrial calcium homeostasis in amyotrophic lateral sclerosis: implications for motoneurons specific calcium dysregulation

  2014cites this paper
• Roles of Vascular Endothelial Growth Factor in Amyotrophic Lateral Sclerosis

  2014cites this paper
• Amyotrophic lateral sclerosis after embolization of cerebral arterioveneous malformations

  2014cites this paper
• The Role of Neuroinflammation in the Pathogenesis of Amyotrophic Lateral Sclerosis

  2014cites this paper
• Vascular endothelial growth factor gene polymorphisms and renal cell carcinoma: A systematic review and meta-analysis

  2013cites this paper
• Barriers to novel therapeutics in amyotrophic lateral sclerosis

  2013cites this paper
• Study of Cyclophilin A Function in Models of Amyotrophic Lateral Sclerosis

  2013cites this paper
• Cellular and molecular mechanisms involved in the neuroprotective effects of VEGF on motoneurons

  2013influential citation
• VEGF ligands and receptors: implications in neurodevelopment and neurodegeneration

  2013cites this paper
• Practice Points Barriers to novel therapeutics in amyotrophic lateral sclerosis MANAGEMENT PERSPECTIVE

  2013cites this paper
• ALS and Oxidative Stress: The Neurovascular Scenario

  2013cites this paper
• Effects of chronic caffeine intake in a mouse model of amyotrophic lateral sclerosis

  2013cites this paper
• Questions regarding the predictive value of one evolved complex adaptive system for a second: exemplified by the SOD1 mouse.

  2013cites this paper
• Genetics of amyotrophic lateral sclerosis: an update

  2013cites this paper
• CSF markers in amyotrophic lateral sclerosis

  2012cites this paper
• Genetics of Familial Amyotrophic Lateral Sclerosis

  2012cites this paper
• Progress in Therapy Development for Amyotrophic Lateral Sclerosis

  2012cites this paper
• Amyotrophic lateral sclerosis: epidemiology, risk factors and treatment

  2012cites this paper
• Genetics of Amyotrophic Lateral Sclerosis

  2012cites this paper
• Potential therapeutic relevance of adenosine A2B and A2A receptors in the central nervous system.

  2012cites this paper
• Genetics of amyotrophic lateral sclerosis

  2012cites this paper
• The complex molecular biology of amyotrophic lateral sclerosis (ALS).

  2012cites this paper
• Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis

  2011cites this paper
• The Expression of VEGF-A Is Down Regulated in Peripheral Blood Mononuclear Cells of Patients with Secondary Progressive Multiple Sclerosis

  2011cites this paper
• The neurovascular link in health and disease: molecular mechanisms and therapeutic implications.

  2011cites this paper
• Cerebrovascular disorders: molecular insights and therapeutic opportunities

  2011cites this paper
• Emerging targets and treatments in amyotrophic lateral sclerosis.

  2011cites this paper
• Energy metabolism in amyotrophic lateral sclerosis.

  2011cites this paper
• Mutant Superoxide Dismutase-1-caused pathogenesis in Amyotrophic Lateral Sclerosis

  2010cites this paper
• Neuronal death in amyotrophic lateral sclerosis (ALS): what can we learn from genetics?

  2010cites this paper
• Oxygen sensing: a common crossroad in cancer and neurodegeneration.

  2010cites this paper
• Lack of association between VEGF gene polymorphisms and plasma VEGF levels and sporadic AL

  2010cites this paper
• The neurobiology of amyotrophic lateral sclerosis

  2010cites this paper
• The 15q24/25 susceptibility variant for lung cancer and chronic obstructive pulmonary disease is associated with emphysema.

  2010cites this paper
• Are anti-angiogenic drugs useful in neurodegenerative disorders?

  2010cites this paper
• VEGF up-regulation by G93A superoxide dismutase and the role of malate-aspartate shuttle inhibition.

  2010cites this paper
• Moving toward a predictive and personalized clinical approach in amyotrophic lateral sclerosis: novel developments and future directions in diagnosis, genetics, pathogenesis and therapies

  2010cites this paper
• Structures of mouse SOD1 and human/mouse SOD1 chimeras.

  2010cites this paper
• Diagnosis, pathogenesis and therapeutic targets in amyotrophic lateral sclerosis.

  2010cites this paper
• RNA metabolism and the pathogenesis of motor neuron diseases.

  2010cites this paper
• Downregulation of genes with a function in axon outgrowth and synapse formation in motor neurones of the VEGFδ/δ mouse model of amyotrophic lateral sclerosis

  2010cites this paper
• Identification of novel Angiogenin (ANG) gene missense variants in German patients with amyotrophic lateral sclerosis

  2009cites this paper
• Analysis of FGGY as a risk factor for sporadic amyotrophic lateral sclerosis

  2009cites this paper
• The genetics of amyotrophic lateral sclerosis.

  2009cites this paper
• CSF profiles of angiogenic and inflammatory factors depend on the respiratory status of ALS patients

  2009cites this paper
• Development of targeted angiogenic medicine

  2009cites this paper
• Genetic studies of amyotrophic lateral sclerosis: Controversies and perspectives

  2009cites this paper
• Amyotrophic lateral sclerosis

  2009cites this paper
• Role and therapeutic potential of VEGF in the nervous system.

  2009cites this paper
• VEGF and ALS.

  2008cites this paper
• Genetics, epigenetics and pharmaco-(epi)genomics in angiogenesis

  2008cites this paper
• The Complex Molecular Biology of Amyotrophic Lateral Sclerosis (als)

  year unknowncites this paper
• Digital Commons@Becker Digital Commons@

  year unknowncites this paper
• Cellular Neuroscience Mini Review Article Trophic Factors as Modulators of Motor Neuron Physiology and Survival: Implications for Als Therapy Trophic Factors during Motor Neuron Development Trophic Factor Effects on Motor Neuron Survival

  year unknowncites this paper